Long-term HAE Prophylaxis with Berotralstat Is Well Tolerated and Effective: Analysis for the APeX-S Study

被引：0
|
作者：
Aygoeren-Puersuen, E. [1 ]
Manning, M. [2 ]
Fain, O. [3 ]
Desai, B. [4 ]
Tomita, D. [4 ]
Johnston, D. T. [4 ]
Li, H. H. [5 ]
Kiani-Alikhan, S. [6 ]
机构：
[1] Goethe Univ, Univ Hosp Frankfurt, Frankfurt, Germany
[2] Allergy Asthma & Immunol Associates Ltd, Scottsdale, AZ USA
[3] Sorbonne Univ, St Antoine Hosp, AP HP, Dept Internal Med, Paris, France
[4] BioCryst Pharmaceut Inc, Durham, NC USA
[5] Inst Asthma & Allergy, Chevy Chase, MD USA
[6] Barts Hlth NHS Trust, Royal London Hosp, London, England
来源：
ALLERGOLOGIE | 2023年 / 46卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P8.02
引用
收藏
页码：556 / 556
页数：1
相关论文
共 50 条
  • [1] Long-term HAE Prophylaxis with Berotralstat Is Well Tolerated and Effective: Analysis for the APeX-S Study
    Aygoeren-Puersuen, Emel
    Manning, Michael
    Fain, Olivier
    Desai, Bhavisha
    Tomita, Dianne
    Johnston, Douglas
    Li, H. Henry
    Kiani-Alikhan, Sorena
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB129 - AB129
  • [2] Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results
    Farkas, H.
    Wu, A. Y.
    Kiani, S.
    Reshef, A.
    Stobiecki, M.
    Kinaciyan, T.
    Maurer, M.
    Aygoren-Pursun, E.
    Dix, D.
    Dobo, S.
    Iocca, H.
    Murray, S.
    Sheridan, W. P.
    Peter, J.
    [J]. ALLERGY, 2020, 75 : 58 - 59
  • [3] Long-term effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study
    Reshef, A.
    Maurer, M.
    Kiani, S.
    Wu, A. Y.
    Stobiecki, M.
    Kinaciyan, T.
    Peter, J.
    Aygoren-Pursun, E.
    Cornpropst, M.
    Nagy, E.
    Murray, S.
    Collis, P.
    Farkas, H.
    [J]. ALLERGY, 2020, 75 : 210 - 211
  • [4] Long-term safety and effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study
    Kiani, Sorena
    Wu, Adrian
    Peter, Jonathan
    Reshef, Avner
    Maurer, Marcus
    Stobiecki, Marcin
    Kinaciyan, Tamar
    Aygoeren-Puersuen, Emel
    Best, Jessica
    Cornpropst, Melanie
    Sheridan, William P.
    Farkas, Henriette
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (01): : 172 - 173
  • [5] Assessment of HAE prophylaxis transition from androgen therapy to berotralstat: A subset analysis of the APeX-S trial
    Peter, Jonny G.
    Desai, Bhavisha
    Tomita, Dianne
    Collis, Phil
    Stobiecki, Marcin
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2023, 16 (11):
  • [6] Long-term safety and effectiveness of berotralstat for hereditary angioedema: The open-label APeX-S study
    Farkas, Henriette
    Stobiecki, Marcin
    Peter, Jonny
    Kinaciyan, Tamar
    Maurer, Marcus
    Aygoren-Pursun, Emel
    Kiani-Alikhan, Sorena
    Wu, Adrian
    Reshef, Avner
    Bygum, Anette
    Fain, Olivier
    Hagin, David
    Huissoon, Aarnoud
    Jesenak, Milos
    Lindsay, Karen
    Panovska, Vesna Grivcheva
    Steiner, Urs C.
    Zubrinich, Celia
    Best, Jessica M.
    Cornpropst, Melanie
    Dix, Daniel
    Dobo, Sylvia M.
    Iocca, Heather A.
    Desai, Bhavisha
    Murray, Sharon C.
    Nagy, Eniko
    Sheridan, William P.
    [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2021, 11 (04)
  • [7] Berotralstat demonstrates consistentlyllow HAE attack rates during COVID-19: subgroup analysis from the apeX-S trial
    Ford, Burnette A.
    Panovska, V. G.
    Desai, B.
    Aggarwal, K.
    Murray, S. C.
    Soteres, D. F.
    [J]. ALLERGY, 2021, 76 : 213 - 214
  • [8] LONG-TERM FLECAINIDE IS EFFECTIVE AND WELL TOLERATED
    GRANRUD, G
    SALERNO, D
    HODGES, M
    KREJCI, J
    LEBENS, P
    ASINGER, R
    [J]. CIRCULATION, 1982, 66 (04) : 69 - 69
  • [9] Berotralstat provides sustained reduction in HAE attack rates and improvement in quality of life in adolescent patients: A subgroup analysis from APeX-S
    Reshef, A.
    Wedner, H. J.
    Johnston, D. T.
    Tomita, D.
    Desai, B.
    Smith, A. M.
    Stobiecki, M.
    Bernstein, J.
    [J]. ALLERGY, 2023, 78
  • [10] Zonisamide is also long-term effective and well-tolerated
    Hausmann, Ralph
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2008, 76 (10) : 570 - 570
12345